Location History:
- Paris, FR (2016)
- Cachan, FR (2018)
Company Filing History:
Years Active: 2016-2018
Title: Pierre Guermonprez: Innovator in Molecular Delivery
Introduction
Pierre Guermonprez is a notable inventor based in Cachan, France. He has made significant contributions to the field of molecular delivery, particularly through his innovative use of adenylcyclase toxin. With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
Guermonprez's latest patents focus on "Vectors for molecule delivery to CD11b expressing cells." This invention relates to a novel use of adenylcyclase toxin in the manufacturing of vectors that target a molecule of interest specifically to CD11b expressing cells. Additionally, the invention encompasses an immunogenic composition that primes immune responses, as well as pharmaceutical compositions and a new vector for molecule delivery to these cells.
Career Highlights
Throughout his career, Pierre Guermonprez has worked with prestigious institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Some of his notable coworkers include Claude Leclerc and Daniel Ladant. Their collaborations have likely enriched his research and led to innovative breakthroughs in the field.
Conclusion
Pierre Guermonprez stands out as an influential inventor in the realm of molecular delivery systems. His patents and collaborations reflect his commitment to advancing medical science and improving therapeutic strategies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.